Federica Toscanini

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Borisov Se, Keertan Dheda, Martin Enwerem et al. · European Respiratory Journal · 2017 · 302 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

Giovanni Novi, Małgorzata Mikulska, Federica Briano et al. · Multiple Sclerosis and Related Disorders · 2020 · 166 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia

Małgorzata Mikulska, Laura Ambra Nicolini, Alessio Signori et al. · PLoS ONE · 2020 · 128 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy

Antonio Vena, Daniele Roberto Giacobbe, Antonio Di Biagio et al. · Clinical Microbiology and Infection · 2020 · 104 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +11

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

Alessandro Grasso, Federica Malfatti, Pasqualina De Leo et al. · Journal of Hepatology · 2009 · 85 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17